Matches in SemOpenAlex for { <https://semopenalex.org/work/W2605491946> ?p ?o ?g. }
- W2605491946 endingPage "130" @default.
- W2605491946 startingPage "115" @default.
- W2605491946 abstract "Drainage of malignant ascites: patient selection and perspectives Maciej Stukan Department of Gynecologic Oncology, Gdynia Oncology Center, Szpitale Wojewodzkie w Gdyni Sp. z o.o., Gdynia, Poland Abstract: Malignant ascites (MA) is a sign of advanced cancer and poor prognosis. MA can result in impairment in quality of life (QOL) and significant symptoms. As a supportive treatment, ascites can be drained by paracentesis (PC), percutaneously implanted catheters (tunneled, untunneled, central venous catheters), or peritoneal ports, or peritoneovenous shunts. The aim of this study was to evaluate the effectiveness, safety, and patient-reported outcomes (PRO) of different drainage methods for the management of MA. A systematic review of the literature was performed, and 32 original articles met the inclusion criteria. Patients selected for permanent drain insertion demonstrated symptoms related to MA and had undergone repeated PC. The primary focus of the reviewed articles was procedural safety issues. The rate of technical success of drainage device installation was 100%. Most patients experienced improvements in symptom control after ascites drainage. When analyzed together, 19.7% (255/1297) of patients experienced any complication and 6.2% (81/1297) experienced serious adverse events during MA drainage. Complications were reported for every drainage method; however, the least occurred after PC or central venous catheter, while the most serious occurred after peritoneovenous shunts. Adverse events were as follows: catheter obstruction: 4.4%, infection: 4.1%, leakage: 3.5%, catheter dislodgment: 2.3%, hypotension: 0.6%, injuries during device insertion: 0.6%, renal impairment: 0.5%, electrolyte imbalance: 0.2%, other: 3.6%. PRO and QOL endpoints were available for 12 studies. When PRO were measured using an interview, a significant improvement in symptom control and QOL was reported in almost all patients. Once standardized questionnaires were used, improvements in symptomatic scores and role functioning were observed. Deterioration was observed in cognitive and emotional subscales. MA drainage is a safe and effective method to control symptoms associated with ascites, and should be perceived as a supportive care, that can be applied for those who need it at any time of their cancer trajectory. Patient selection should be performed using a thorough assessment of symptoms and QOL, and should not be delayed. Keywords: ascites, malignant, cancer, drainage, complications, quality of life, symptoms, palliation, support, catheter, peritoneal port, paracenetesis, shunt, effectiveness, management" @default.
- W2605491946 created "2017-04-28" @default.
- W2605491946 creator A5064149216 @default.
- W2605491946 date "2017-04-01" @default.
- W2605491946 modified "2023-10-01" @default.
- W2605491946 title "Drainage of malignant ascites: patient selection and perspectives" @default.
- W2605491946 cites W147829601 @default.
- W2605491946 cites W1528565630 @default.
- W2605491946 cites W1885017037 @default.
- W2605491946 cites W1968413168 @default.
- W2605491946 cites W1978503687 @default.
- W2605491946 cites W1980261320 @default.
- W2605491946 cites W1980689809 @default.
- W2605491946 cites W1981650424 @default.
- W2605491946 cites W1983412575 @default.
- W2605491946 cites W1989230498 @default.
- W2605491946 cites W1991391990 @default.
- W2605491946 cites W2018709904 @default.
- W2605491946 cites W2019431907 @default.
- W2605491946 cites W2024413804 @default.
- W2605491946 cites W2034209565 @default.
- W2605491946 cites W2036290945 @default.
- W2605491946 cites W2038032526 @default.
- W2605491946 cites W2038765786 @default.
- W2605491946 cites W2043285573 @default.
- W2605491946 cites W2045004079 @default.
- W2605491946 cites W2045119449 @default.
- W2605491946 cites W2045723186 @default.
- W2605491946 cites W2048568093 @default.
- W2605491946 cites W2048843022 @default.
- W2605491946 cites W2049009845 @default.
- W2605491946 cites W2062747754 @default.
- W2605491946 cites W2063724277 @default.
- W2605491946 cites W2064351726 @default.
- W2605491946 cites W2070187007 @default.
- W2605491946 cites W2071012069 @default.
- W2605491946 cites W2077255241 @default.
- W2605491946 cites W2083797416 @default.
- W2605491946 cites W2085204956 @default.
- W2605491946 cites W2088161755 @default.
- W2605491946 cites W2094232837 @default.
- W2605491946 cites W2107426368 @default.
- W2605491946 cites W2114315950 @default.
- W2605491946 cites W2121080406 @default.
- W2605491946 cites W2128455375 @default.
- W2605491946 cites W2138550436 @default.
- W2605491946 cites W2150616104 @default.
- W2605491946 cites W2152555949 @default.
- W2605491946 cites W2156694065 @default.
- W2605491946 cites W2169205464 @default.
- W2605491946 cites W2183391686 @default.
- W2605491946 cites W2187153308 @default.
- W2605491946 cites W2201020857 @default.
- W2605491946 cites W2339694803 @default.
- W2605491946 cites W2354201358 @default.
- W2605491946 cites W2412165478 @default.
- W2605491946 cites W47656826 @default.
- W2605491946 cites W2069474788 @default.
- W2605491946 doi "https://doi.org/10.2147/cmar.s100210" @default.
- W2605491946 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5396842" @default.
- W2605491946 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28442933" @default.
- W2605491946 hasPublicationYear "2017" @default.
- W2605491946 type Work @default.
- W2605491946 sameAs 2605491946 @default.
- W2605491946 citedByCount "51" @default.
- W2605491946 countsByYear W26054919462017 @default.
- W2605491946 countsByYear W26054919462018 @default.
- W2605491946 countsByYear W26054919462019 @default.
- W2605491946 countsByYear W26054919462020 @default.
- W2605491946 countsByYear W26054919462021 @default.
- W2605491946 countsByYear W26054919462022 @default.
- W2605491946 countsByYear W26054919462023 @default.
- W2605491946 crossrefType "journal-article" @default.
- W2605491946 hasAuthorship W2605491946A5064149216 @default.
- W2605491946 hasBestOaLocation W26054919461 @default.
- W2605491946 hasConcept C126322002 @default.
- W2605491946 hasConcept C141071460 @default.
- W2605491946 hasConcept C18903297 @default.
- W2605491946 hasConcept C197934379 @default.
- W2605491946 hasConcept C2776258039 @default.
- W2605491946 hasConcept C2777720800 @default.
- W2605491946 hasConcept C2780496750 @default.
- W2605491946 hasConcept C2781267111 @default.
- W2605491946 hasConcept C67592535 @default.
- W2605491946 hasConcept C71924100 @default.
- W2605491946 hasConcept C81182388 @default.
- W2605491946 hasConcept C86803240 @default.
- W2605491946 hasConceptScore W2605491946C126322002 @default.
- W2605491946 hasConceptScore W2605491946C141071460 @default.
- W2605491946 hasConceptScore W2605491946C18903297 @default.
- W2605491946 hasConceptScore W2605491946C197934379 @default.
- W2605491946 hasConceptScore W2605491946C2776258039 @default.
- W2605491946 hasConceptScore W2605491946C2777720800 @default.
- W2605491946 hasConceptScore W2605491946C2780496750 @default.
- W2605491946 hasConceptScore W2605491946C2781267111 @default.
- W2605491946 hasConceptScore W2605491946C67592535 @default.
- W2605491946 hasConceptScore W2605491946C71924100 @default.
- W2605491946 hasConceptScore W2605491946C81182388 @default.